INTERNATIONAL PATENT: KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD., 康百达（四川）生物医药科技有限公司 FILES APPLICATION FOR "PHARMACEUTICAL COMBINATION OF PARP7 INHIBITOR COMBINED MEDICATION AND USE THEREOF IN TREATING TUMORS"

Posted On: 2025-05-26

GENEVA, May 26 -- KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD. (No.433, Anxian Road, Section 3, Knight Avenue, Wenjiang District,Chengdu, Sichuan 610000), 康百达（四川）生物医药科技有限公司 (中国四川省成都市温江区骑士大道三段安贤路433号) filed a patent application (PCT/CN2024/131698) for "PHARMACEUTICAL COMBINATION OF PARP7 INHIBITOR COMBINED MEDICATION, AND USE THEREOF IN TREATING TUMORS" on Nov 13, 2024. With publication no. WO/2025/103341, the details related to the patent application was published on May 22, 2025....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD., 康百达（四川）生物医药科技有限公司 FILES APPLICATION FOR "PHARMACEUTICAL COMBINATION OF PARP7 INHIBITOR COMBINED MEDICATION AND USE THEREOF IN TREATING TUMORS"